SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Dino's Bar & Grill

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew~ who wrote (13573)8/4/2015 9:04:51 AM
From: Goose94Read Replies (2) of 203030
 
Patient Home Monitoring (PHM-V) top two officials quietly sold the bulk of their shares two months after promoting a $67-million stock sale. Jacquie McNish and Niall McGee write that PHM saw its stock soar from a low of 33 cents a share last summer to a high in April of nearly $2 on promises from two Los Angeles based promoters, Michael Dalsin and Roger Greene, that PHM was poised for greatness.

In May, the two men predicted PHM would be transformed by an acquisition spree that would catapult 2014 annual sales of $21-million to $175-million in 2015. A long-term target of $1-billion, Mr. Greene told a Midas Letter interviewer, was "realistic."

The rosy outlook helped a trio of Bay Street underwriters sell $67-million of stock units to a broad group of affluent and institutional investors in May. Investor enthusiasm turned to outrage last week, when it became public knowledge that Mr. Dalsin and Mr. Greene had sold their jointly held interest of 13.4 million shares in PHM on July 14 for $18.2-million or $1.36 a share. The two men, who are company directors, have not offered a public explanation for their abrupt stock sale.

Message 30174763
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext